Published by the Pulmonary Fibrosis Foundation, this February 2025 update provides a helpful overview of current clinical trials available for people with PF and other interstitial lung diseases. It includes studies focused on new antifibrotic drugs, treatments for progressive pulmonary fibrosis, and therapies for PF-associated pulmonary hypertension.
Each trial listing includes key information like eligibility, treatment type, and location. The article encourages patients to consider participation and explains how clinical trials contribute to future treatment breakthroughs. It also highlights tools like the PFF Clinical Trial Finder, designed to match patients with suitable studies.
This piece helps demystify the clinical trial process and promotes patient empowerment through informed participation.
